ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

New TNF-Alpha Inhibitor for Rheumatoid Arthritis

  [ 11 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 27, 2002




Isis Pharmaceuticals, Inc. announced it has initiated a Phase II clinical trial of ISIS 104838, an inhibitor of tumor necrosis factor-alpha (TNF-alpha), in rheumatoid arthritis (RA).

The Phase II clinical trial will evaluate the safety and efficacy of ISIS in RA when administered by subcutaneous injection (SQ) for three months. This is the second Phase II study of ISIS currently in progress.

TNF-alpha is a naturally occurring cytokine that is involved in the development and progression of many inflammatory diseases, including RA. The double-masked, placebo-controlled, randomized Phase II study is planned to enroll 160 people with RA at 25 sites in the U.S. and Canada.

Three dosing regimens will be examined in this study: ISIS injections twice a week, once a week or once every other week. The primary endpoint in the study is improvement in American College of Rheumatology (ACR) response criteria, which measures improvement in patient and professional reported disease severity and activity.

"We are pleased to begin the second study of ISIS in people with rheumatoid arthritis, and to move forward with the clinical development of our new generation of antisense drugs. The initial Phase II trial, which began last November, is studying ISIS drug concentrations in tissue and blood as well as the drug's ability to reduce TNF-alpha levels. This new trial will be the first to provide efficacy information about ISIS in RA. We will use the combined results from the two studies to direct our future development plans with this drug," said F. Andrew Dorr, M.D., Isis Vice President and Chief Medical Officer.

Isis' first Phase II clinical trial of ISIS is evaluating the biological effect of TNF-alpha inhibition by ISIS in 20 RA patients over a four-week treatment period.

Phase I trials of intravenous infusion and SQ administration of ISIS demonstrated enhanced tolerability, duration of effect and dosing convenience compared with first-generation drugs.





Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® FibroSleep™ Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

The Fast-Acting Solution for Healthy Digestive Function The Fast-Acting Solution for Healthy Digestive Function
Safely Burn Away Body Fat Safely Burn Away Body Fat
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map